Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study

BACKGROUND: Few Saudi studies have examined adverse drug reactions (ADRs) in patients with rheumatoid arthritis (RA) receiving intravenous (IV) originator biologics. Therefore, this study aimed to evaluate the prevalence, types, and predictors of ADRs following long-term IV originator biologic use i...

Descripción completa

Detalles Bibliográficos
Autores principales: Almalag, Haya M., Alaujan, Shiekha S., Alhazzani, Hawazin S., Alzamel, Lamia A., Tashkandi, Reem S., Alarfaj, Hussain F., Alarfaj, Abdurhman S., Omair, Mohammed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315253/
https://www.ncbi.nlm.nih.gov/pubmed/35903531
http://dx.doi.org/10.1016/j.jsps.2022.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315253/
https://www.ncbi.nlm.nih.gov/pubmed/35903531
http://dx.doi.org/10.1016/j.jsps.2022.04.008

Ejemplares similares